IRTC (iRhythm Technologies) ROE % Adjusted to Book Value : -0.21% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is iRhythm Technologies ROE % Adjusted to Book Value?

iRhythm Technologies's ROE % for the quarter that ended in Dec. 2024 was -6.56%. iRhythm Technologies's PB Ratio for the quarter that ended in Dec. 2024 was 31.14. iRhythm Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -0.21%.

iRhythm Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for iRhythm Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies ROE % Adjusted to Book Value Chart

iRhythm Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-0.91

-2.63

-3.79

-3.48

-2.42

iRhythm Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-4.57	-3.04	-2.51	-6.68	-0.21

Competitive Comparison of iRhythm Technologies's ROE % Adjusted to Book Value

For the Medical Devices subindustry, iRhythm Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iRhythm Technologies's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

iRhythm Technologies ROE % Adjusted to Book Value Calculation

iRhythm Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-75.27%	/	31.14
	=	-2.42%

iRhythm Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-6.56%	/	31.14
	=	-0.21%

iRhythm Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

iRhythm Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (NAS:IRTC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0A7L:UK

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Executives

Minang Turakhia	officer: EVP, CMO & CSO	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Daniel G. Wilson	officer: EVP, Strategy Corp Dev Inv Rel	699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Quentin S. Blackford	director, officer: President and CEO	7475 LUSK BLVD., SAN DIEGO CA 92121
Patrick Michael Murphy	officer: CLO & EVP RA/QA MrktAcs & Gov	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Sumi Shrishrimal	officer: EVP, Chief Risk Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Chad Patterson	officer: Chief Commercial Officer	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Abhijit Y Talwalkar	director	ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088
Brice Bobzien	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Mervin Smith	officer: EVP Strategic Business Ops	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103
Marc W. Rosenbaum	officer: Chief Accounting Officer	7475 LUSK BLVD., SAN DIEGO CA 92121
Mark J. Day	officer: EVP, Research & Development	C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103
Brian B Yoor	director	100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064
Mojdeh Poul	director	3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST PAUL MN 55144-1000
Douglas Devine	officer: Chief Financial Officer	C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103
Bairey Merz Cathleen Noel	director	16664 CUMBRE VERDE COURT, PACIFIC PALISADES CA 90272